Capecitabine
Drug Details
- Description
- Capecitabine is an oral chemotherapy drug used to treat certain types of cancer, including breast and colorectal cancer. It is a prodrug that is metabolized in the body to 5-fluorouracil (5-FU), which inhibits DNA synthesis and slows cancer cell growth.
- Alternative Names
- Capecitabine is commonly referred to as Xeloda.
- Key Genes
- Key genes associated with capecitabine include DPYD, TYMS, and MTHFR. Variants in DPYD can impact drug metabolism and toxicity, while TYMS and MTHFR variations can influence efficacy and side effects.
- Drug Use
- Capecitabine is used to treat certain types of cancers, including breast cancer and colorectal cancer. It is an oral chemotherapy medication that interferes with the growth of cancer cells.
- Genetic Factors Influencing Response
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Purchase Membership to Access Your Individual Drug Response Report